Búsqueda

IDIOMA/LANGUAGE

Bandera inglesa Bandera espanola

Publicaciones

  • ÁREA TERAPÉUTICA VIH Y SIDA
Comunicaciones GESIDA

Ocampo A, Domingo P, Fernández P, Diz J, Barberá JR, Sepúlveda MA, Salgado X, Rodriguez M, Santos J, Yzusqui M, Castaño M, Lorenzo JF, Bahamonde A, Bachiller P, Martínez E, Rozas N, Torres C, Muñoz A, Podzamczer D

Lipid Changes And Tolerability In A Cohort Of Adult HIV-infected Patients Switching To RPV/FTC/TDF, Due To Intolerance To Previous cART. A Substudy Of PRO-STR Study.
VII Congreso Nacional de Gesida. Madrid, Spain. 1-4 dic 2015.

Comunicaciones GESIDA

Podzamczer D, Rozas N, Domingo P, Ocampo A,Van den Eynde E, Vergara A, Deig E, Knobel H, Pasquau J, Antela A, Crespo M, Clotet B, Geijo P, Rodríguez de Castro E, Casado A

Clinical Data And Patient-Reported Outcomes (PRO) In HIV-Infected Adults Switching To RPV/FTC/TDF, Due To A Previous Intolerance To cART. Interim Analysis Of The PRO-STR Study.

VII Congreso Nacional de Gesida. Madrid, Spain. 1-4 dic 2015.

Comunicaciones EACS

Podzamczer D, Rozas N, Domingo P, Ocampo A,Van den Eynde E, Vergara A, Deig E, Knobel H, Pasquau J, Antela A, Crespo M, Clotet B, Geijo P, Rodríguez de Castro E, Casado A

Clinical Data And Patient-Reported Outcomes (PRO) In HIV-Infected Adults Switching To RPV/FTC/TDF, Due To A Previous Intolerance To cART. Interim Analysis Of The PRO-STR Study.

15th European AIDS Conference (EACS). Barcelona, Spain. 21-24 oct 2015.

Comunicaciones EACS

Ocampo A, Domingo P, Fernández P, Diz J, Barberá JR, Sepúlveda MA, Salgado X, Rodriguez M, Santos J, Yzusqui M, Castaño M, Lorenzo JF, Bahamonde A, Bachiller P, Martínez E, Rozas N, Torres C, Muñoz A, Podzamczer D

Lipid Changes And Tolerability In A Cohort Of Adult HIV-infected Patients Switching To RPV/FTC/TDF, Due To Intolerance To Previous cART. A Substudy Of PRO-STR Study.

15th European AIDS Conference (EACS). Barcelona, Spain. 21-24 oct 2015.

Comunicaciones GESIDA

Pérez-Valero I, Martín-Quirós A, Roldán C, Díaz M, Torres C, Bernardino JI, Zamora FX, Pascual F, Arribas JR, González L, Herrero A, Casado MA, De La Puente M, González-Garcia J

Estudio de Coste-Efectividad de las estrategias terapéuticas actuales de simplificación del tratamiento antrirretroviral-Estudio Gesida 6911.

V Congreso Nacional GeSIDA. Sitges, España. 19-22 nov 2013.

Comunicaciones EAHP

Homar F, Lozano V, Oyagüez I, Casado MA

Cost analysis of antiretroviral treatment and drug-related adverse events of fixed-dose combinations of antiretrovirals versus separate components in HIV-1 therapy.

17th Congress of European Association of Hospital Pharmacist (EAHP). Milan, Italy. 21-23 mar 2012.

Comunicaciones EACS

Moreno S, Casado MA, Domingo P, Llibre JM, Martínez E, Miralles C, Santos J, Pérez-Elías MJ, Alvarez ML

Tenofovir DF is associated with decreased HIV-related healthcare costs in HIV-1-infected heavily pre-treated patients with nucleoside reverse transcriptase inhibitors-related toxicity.

10th European AIDS Conference / EACS. Dublin, Ireland. 17-20 nov 2005.

Comunicaciones ADRL

Moreno S, Casado MA, Domingo P, Llibre JM, Martínez E, Miralles C, Santos J, Pérez-Elías MJ, Sánchez de la Rosa R

Cost of the NRTI-related toxicities in HIV-1-infected heavily experienced patients.

7th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. Dublin, Ireland. 13-16 nov 2005.